01—Abstract
Summary
Summary of the 10-Q filed May 1, 2024. Cited figures are marked; the original filing is the authoritative source.
CVS Health Corporation reported total revenues of $88.4 billiona for the first quarter of 2024, a 3.7% increase compared to the prior year, primarily driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments.
However, net income attributable to CVS Health significantly decreased by 47.9% to $1.113 billionb ($0.88 diluted EPS) from $2.136 billion ($1.65 diluted EPS) in the first quarter of 2023. This decline was largely attributed to increased Medicare utilization, unfavorable impacts from lower Medicare Advantage star ratings, and higher health care costs in the Health Care Benefits segment, as well as challenges in the Health Services segment including client price improvements and the loss of a large client. The company's operational performance reflects a mixed picture, with revenue growth being overshadowed by a substantial drop in profitability.
While the Health Care Benefits segment saw strong revenue growth from Medicare and Commercial product lines, its Medical Benefit Ratio (MBR) increased significantly due to higher utilization. The Health Services segment experienced a revenue decline primarily due to client losses and pricing pressures, despite contributions from recent acquisitions. The Pharmacy & Consumer Wellness segment demonstrated solid revenue growth driven by increased prescription volume and favorable drug mix, alongside a slight increase in adjusted operating income.
CVS Health's balance sheet remains robust with total assets of $249.7 billionc. The company also continued its share repurchase program, repurchasing $3.0 billion of common stock in the quarter. Despite the profitability dip, the company's outlook suggests expected growth from new ventures like Cordavis, Oak Street Health, and Signify Health, though it anticipates continued pressure on its Health Care Benefits segment due to sustained high Medicare utilization.
02—Key points
Key Highlights
- Total revenues increased by 3.7% to $88.4 billion in Q1 2024, driven by Health Care Benefits and Pharmacy & Consumer Wellness segments.
- Net income attributable to CVS Health decreased significantly by 47.9% to $1.113 billion, with diluted EPS falling to $0.88 from $1.65 year-over-year.
- The Health Care Benefits segment experienced a substantial 69.6% drop in operating income, primarily due to increased Medicare utilization and lower Medicare Advantage star ratings, leading to a higher Medical Benefit Ratio (MBR) of 90.4%.
- The Health Services segment saw a 9.7% decline in total revenues due to client loss and pricing pressures, resulting in a 18.9% decrease in adjusted operating income.
- The Pharmacy & Consumer Wellness segment reported a 2.9% increase in total revenues and a 3.8% rise in adjusted operating income, supported by higher prescription volumes and favorable drug mix.
- CVS Health repurchased $3.0 billion of its common stock in the first quarter of 2024.
- The company anticipates continued pressure on its Health Care Benefits segment due to persistent high Medicare utilization in the near term.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2024, CVS Health Corp kept $0.01.
- Revenue$88.44B100.0%
- Cost of revenue−$48.07B54.4%
- Gross profit$40.36B45.6%
- Operating costs−$38.09B43.1%
- Operating income$2.27B2.6%
- Interest, other & tax−$1.15B1.3%
- Net income$1.12B1.3%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2024filed May 1, 2024Financial Statements
Q1 FY2024 against Q1 FY2023
| Line item | Q1 FY2024Q1 FY2023 | Change |
|---|---|---|
| Revenue | $88.44B$85.28B | +3.7% |
| Cost of Revenue | $48.07B$51.45B | −6.6% |
| Gross Profit | $40.36B$33.82B | +19.3% |
| Operating Expenses | $86.17B$81.83B | +5.3% |
| Operating Income | $2.27B$3.45B | −34.1% |
| Interest Expense | $716.00M$589.00M | +21.6% |
| Net Income | $1.12B$2.14B | −47.5% |
| EPS (Basic) | $0.88$1.66 | −47.0% |
| EPS (Diluted) | $0.88$1.65 | −46.7% |
| Shares Outstanding (Basic) | 1.26B1.28B | −1.8% |
| Shares Outstanding (Diluted) | 1.27B1.29B | −1.9% |
05—Questions
Frequently Asked Questions
What is the primary reason for the significant decrease in net income compared to the previous year?
The significant decrease in net income is primarily due to increased Medicare utilization, an unfavorable impact from the decline in the Company's 2024 Medicare Advantage star ratings, and a year-over-year unfavorable impact from the development of prior-years' health care cost estimates in the Health Care Benefits segment. Additionally, the Health Services segment faced challenges with continued pharmacy client price improvements, lower contributions from 340B, and the loss of a large client.
How did the different business segments perform in the first quarter of 2024?
The Health Care Benefits segment saw strong revenue growth but a significant drop in operating income due to higher medical costs. The Health Services segment experienced a decrease in total revenues and adjusted operating income, impacted by client losses and pricing pressures. The Pharmacy & Consumer Wellness segment showed growth in total revenues and a slight increase in adjusted operating income, driven by prescription volume and drug mix.
What is the company's outlook regarding Medicare Advantage utilization?
CVS Health expects continued elevated Medicare utilization to pressure its Health Care Benefits segment and its health care delivery assets in the Health Services segment for the remainder of the year. This trend has already contributed to increased health care costs and a higher Medical Benefit Ratio (MBR).
What is the company doing with its cash flow, particularly concerning shareholders?
In the first quarter of 2024, CVS Health repurchased approximately $3.0 billion of its common stock under its share repurchase program. The company also declared a quarterly cash dividend of $0.665 per share.
06—Continue